Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders

摘要

Pharmaceutical composition comprising 25 to 450 mg dipyridamole or its Salt, in combination with at least an antithrombotic Agent, or in combination with an ace Inhibitor, angiotensin II antagonist.- ca antagonist or a Lipid Lowering Agent, and its use in treating disorders of microcirculation of fibrin dependent.